Literature DB >> 22555031

Evaluation of the resistive index of prostatic blood flow in benign prostatic hyperplasia.

Osama Abdelwahab1, Ehab El-Barky, Mostafa Mahmoud Khalil, Ahmad Kamar.   

Abstract

OBJECTIVE: The aim of this work is to study the resistive index (RI) of prostatic blood flow by transrectal power Doppler sonography in benign prostatic hyperplasia (BPH) to determine its correlation with other parameters of BPH.
MATERIALS AND METHODS: Eighty-two male patients aged 52-86 years with lower urinary tract symptoms (LUTS) due to BPH were included in the study. Patients with prostate cancer, neurogenic bladder, or with other pathology (e.g. prostatitis, bladder stone) were excluded from the study. All patients were evaluated by full history including Internatinoal Prostate Symptoms Score (IPSS), general and local examination (DRE), neurologic examination, uroflowmetry, laboratory investigations including urine analysis, routine laboratory tests and serum prostate specific antigen (PSA). Transrectal ultrasonography was used to calculate the total prostatic volume. Transrectal Power Doppler Ultrasound (PUD) was used to identify the capsular and urethral arteries of the prostate and to measures the RI value.
RESULTS: The mean prostate volume was 75.1 ± 44.7 g. The mean RI of the right and left capsular arteries were 0.76 ± 0.06 and 0.76 ± 0.07, respectively. The mean RI of the urethral arteries was 0.76 ± 0.08. There was a high significative correlation between the increase of the RI of the right and left capsular and urethral arteries and the degree of obstruction (P value < 0.001), severity of symptoms (P value < 0.001) and also the prostatic volume (P value < 0.001).
CONCLUSION: Resistive index of the prostatic blood flow can be applied as an easy and non-invasive tool to evaluate the lower urinary tract obstruction due to BPH.

Entities:  

Mesh:

Year:  2012        PMID: 22555031     DOI: 10.1590/s1677-55382012000200014

Source DB:  PubMed          Journal:  Int Braz J Urol        ISSN: 1677-5538            Impact factor:   1.541


  4 in total

Review 1.  Tadalafil for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a review of clinical data in Asian men and an update on the mechanism of action.

Authors:  Osamu Yokoyama; Yasuhiko Igawa; Masayuki Takeda; Takafumi Yamaguchi; Masahiro Murakami; Lars Viktrup
Journal:  Ther Adv Urol       Date:  2015-10

2.  Inhibitory effects of Hydrocotyle ramiflora on testosterone-induced benign prostatic hyperplasia in rats.

Authors:  Suyoung Park; Youn-Hwan Hwang; Eun-Bok Baek; Eun-Ju Hong; Young-Suk Won; Hyo-Jung Kwun
Journal:  Int Urol Nephrol       Date:  2022-09-15       Impact factor: 2.266

3.  B-Mode and Doppler Ultrasonographic Findings of Prostate Gland and Testes in Dogs Receiving Deslorelin Acetate or Osaterone Acetate.

Authors:  Wojciech Niżański; Małgorzata Ochota; Christelle Fontaine; Joanna Pasikowska
Journal:  Animals (Basel)       Date:  2020-12-11       Impact factor: 2.752

4.  Transrectal Doppler Sonography of Benign Prostatic Enlargement in Nigerian Men.

Authors:  Olubukola Olayinka Fanimi; Christianah Mopelola Asaleye; Abdulkadir Ayo Salako; Oluwagbemiga Oluwole Ayoola; Tewogbade Adeoye Adedeji; Bukunmi Michael Idowu
Journal:  J Med Ultrasound       Date:  2019-05-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.